Nutex Health Inc.
NUTX
$122.90
$4.443.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 211.79M | 257.62M | 78.79M | 76.08M | 67.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 211.79M | 257.62M | 78.79M | 76.08M | 67.45M |
| Cost of Revenue | 88.36M | 110.71M | 51.91M | 48.99M | 53.11M |
| Gross Profit | 123.43M | 146.91M | 26.89M | 27.09M | 14.34M |
| SG&A Expenses | 46.13M | 27.43M | 11.83M | 10.59M | 8.71M |
| Depreciation & Amortization | 5.09M | 5.28M | 4.97M | 4.53M | 4.19M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 139.58M | 143.42M | 68.71M | 64.11M | 66.00M |
| Operating Income | 72.21M | 114.20M | 10.09M | 11.97M | 1.45M |
| Income Before Tax | 62.76M | 108.58M | -2.58M | 3.90M | -152.00K |
| Income Tax Expenses | 18.54M | 8.61M | 4.58M | 893.90K | 390.00K |
| Earnings from Continuing Operations | 44.22M | 99.97M | -7.17M | 3.01M | -542.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.59M | -38.27M | -1.62M | -3.37M | 178.00K |
| Net Income | 14.63M | 61.70M | -8.79M | -364.00K | -364.00K |
| EBIT | 72.21M | 114.20M | 10.09M | 11.97M | 1.45M |
| EBITDA | 74.01M | 127.07M | 12.15M | 14.05M | 3.41M |
| EPS Basic | 2.65 | 11.83 | -1.72 | -0.07 | -0.08 |
| Normalized Basic EPS | 1.75 | 5.67 | -0.58 | 0.65 | 0.02 |
| EPS Diluted | 2.56 | 11.12 | -1.72 | -0.07 | -0.08 |
| Normalized Diluted EPS | 1.65 | 5.33 | -0.58 | 0.65 | 0.02 |
| Average Basic Shares Outstanding | 5.52M | 5.22M | 5.10M | 4.97M | 4.85M |
| Average Diluted Shares Outstanding | 5.85M | 5.55M | 5.10M | 4.97M | 4.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 50.32% | -- | -- | -- | -132.14% |